FOCUS DAILIES TORIC
Report
- Report Number
- 9610813-2014-00010
- Event Type
- Injury
- Date Received
- May 28, 2014
- Date of Event
- February 23, 2014
- Report Date
- May 1, 2014
- Manufacturer
- CIBA VISION GMBH
- Product Code
- MVN
- PMA / PMN Number
- K050065
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- CA
- Reporter Occupation
- NOT APPLICABLE
Narratives
(B)(4). THE DEVICE HISTORY RECORD AND STERILIZATION RECORD FOR THIS LOT HAVE BEEN REVIEWED AND FOUND TO BE IN COMPLIANCE. THE COMPLAINT PRODUCT WAS NOT RETURNED FOR EVALUATION. RETAINED PRODUCT FROM THE SAME LOT WAS EVALUATED AND ALL TESTING WAS FOUND TO BE WITHIN SPECIFICATION. THERE WERE NO NON-CONFORMITIES OR DEVIATIONS DURING THE MANUFACTURING PROCESS WHICH RELATED TO THE NATURE OF THE COMPLAINT. THE ROOT CAUSE COULD NOT BE DETERMINED. (B)(4).
IT WAS REPORTED BY THE EYE CARE PROFESSIONAL (ECP) THAT A PATIENT WAS SEEN FOR AN ULCER IN THE LEFT EYE AND THINKS IT MAY BE CONTACT LENS RELATED. ADDITIONAL INFORMATION RECEIVED FROM THE TREATING ECP ON (B)(6) 2014, STATING THAT THE PATIENT WAS DIAGNOSED WITH A CENTRAL BACTERIAL CORNEAL ULCER, 0.5MM IN SIZE, IN THE LEFT EYE ON (B)(6) 2014. THE PATIENT EXPERIENCED MODERATE PAIN/DISCOMFORT, MODERATE REDNESS, WATERY DISCHARGE, A MILD ANTERIOR CHAMBER REACTION, AND MODERATE STAINING OVER LESS THAN 50% OF THE CORNEA. ONE CENTRAL INFILTRATE, 0.5MM IN SIZE, WAS PRESENT, AND PERMANENT SCARRING WAS NOTED. THE PATIENT WAS PRESCRIBED VIGAMOX, EVERY 30 MINUTES IN THE LEFT EYE, ALTERNATING WITH TOBRAMYCIN GTT EVERY 30 MINUTES AND ERYTHROMYCIN UNG QHS AND HOMATROPINE 2% BID. FOLLOW UP WAS SCHEDULED FOR (B)(6) 2014, AND THEN EVERY FEW DAYS. THE BEST CORRECTED VISUAL ACUITY PRIOR TO AND AFTER THE EVENT WAS 20/20. THE EVENT HAS RESOLVED AND LENS WEAR HAS RESUMED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 314202 | FOCUS DAILIES TORIC | LENS, CONTACT (DISPOSABLE) | MVN | CIBA VISION GMBH | N0528180 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 35 YR | Other |